Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00581568 · ClinicalTrials.gov registry record · Phase 1
Cutaneous Effects of Cryogen Spray Cooling
A Phase 1 study of Pain, sponsored by University of California, Irvine.
- Completed
- Registry status
- Phase 1
- Development phase
- 53
- Enrollment target
- 1
- Study location
NCT00581568 is a Phase 1 study of Pain that has completed, run by University of California, Irvine. The registered enrollment target is 53 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00581568, a Phase 1 study of Pain, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 53 participants
- Enrollment target
- 1
- Study location
Study Summary
Cryogen Spray Cooling spurt is applied to the skin surface immediately before laser exposure. As liquid cryogen rapidly evaporates, the superficial skin temperature is reduced as a result of supplying the latent heat of vaporization. Tetrafluoroethane, an environmentally compatible, non-toxic, non-flammable freon substitute, has been demonstrated in multiple studies to be a safe and effective cooling agent and is the only cryogenic compound currently approved for dermatologic use by the Food and Drug Administration.
Conditions Studied
Interventions
- OTHER Cutaneous Effects of Cryogen Spray Cooling
Study Locations (1)
California
- Beckman Laser Institute Medical and Surgical clinic - Irvine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2004-01 |
| Est. Completion | 2010-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00581568
The ClinicalTrials.gov registry entry for NCT00581568 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (83% lower). The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 1 intervention - of which Cutaneous Effects of Cryogen Spray Cooling is the first listed.
NCT00581568 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00581568 about?
NCT00581568 is a clinical study titled "Cutaneous Effects of Cryogen Spray Cooling". Cryogen Spray Cooling spurt is applied to the skin surface immediately before laser exposure. As liquid cryogen rapidly evaporates, the superficial skin temperature is reduced as a result of supplying the latent heat of vaporization. Tetrafluoroethane, an environmentally compatible, non-toxic, non-f...
What is the current status of trial NCT00581568?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 53 participants. The study started on 2004-01. Estimated completion is 2010-09.
What conditions does trial NCT00581568 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT00581568?
The interventions under investigation include: Cutaneous Effects of Cryogen Spray Cooling (OTHER).
Who is sponsoring clinical trial NCT00581568?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00581568 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
THC and CBD: A Controlled Human Study Probing a Harm Reduction Strategy
RECRUITING · Phase 1
-
Evaluation of the Excretion of Suzetrigine Into Breast Milk in Healthy Lactating Female Participants
RECRUITING · Phase 1
-
Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery
RECRUITING · Phase 1
-
High Potency Cannabis: Acute and Protracted Effects
RECRUITING · Phase 1
-
Phase 1 Study of SBS-147 in Healthy Adults
RECRUITING · Phase 1
-
Patient Controlled Administration of Liquid Acetaminophen
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.